Dasatinib 50 mg

Dasatinib 50 mg is a targeted therapy medication used to treat certain types of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting the BCR-ABL enzyme, which is responsible for the abnormal growth and survival of cancer cells.

Uses:

• Treatment of chronic myeloid leukemia (CML) in adults.
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults.

Important Considerations:

1. Prescription Medication: Dasatinib is a prescription medication. Consult with a healthcare professional before use.
2. Potential Side Effects: Common side effects may include fluid retention, fatigue, nausea, vomiting, and diarrhea. Serious side effects can occur. If you experience any adverse effects, contact your doctor immediately.
3. Medication Interactions: Dasatinib may interact with other medications. Inform your doctor about all prescription and over-the-counter drugs you are taking.